MiRNA as potential biomarkers and therapeutic targets for gastric cancer

doi:10.3748/wjg.v20.i30.10432

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 30

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10018)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-1) series.

Item

Count

PDF

886

WORD

236

HTML

7431

Tables (1-1)

108

Sum=8661

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

840

Download

517

Sum=1357

Aug 14, 2014 (publication date) through May 23, 2024

Times Cited of This Article

Times Cited (237)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Aug 14, 2014; 20(30): 10432-10439
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10432

MiRNA as potential biomarkers and therapeutic targets for gastric cancer

Vivian Yvonne Shin, Kent-Man Chu

Vivian Yvonne Shin, Kent-Man Chu, Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China

Author contributions: Shin VY and Chu KM contributed to the writing of the manuscript.

Correspondence to: Kent-Man Chu, Professor, Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong, China. chukm@hku.hk

Telephone: +852-2255-4637 Fax: +852-2819-4221

Received: October 28, 2013
Revised: February 4, 2014
Accepted: April 27, 2014
Published online: August 14, 2014

Core Tip

Core tip: This minireview summarized the most up-to-date important microRNAs (miRNAs) involved in tumor progression and development in gastric cancer. The potential use of miRNAs in the different areas of clinical settings is discussed.